ArticleFrontiers in immunology2025

IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models.

Chongfeng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.